DNA Sequencing Market Reached US$ 15.2 Billion in 2024 and Is Projected to Reach US$ 45.8 Billion by 2033 at a CAGR of 13.1%; North America Leads with 48% Share - Key Players: Illumina, Thermo Fisher Scientific, BGI Genomics

The global DNA sequencing market reached US$ 15.2 billion in 2024 and is expected to reach US$ 45.8 billion by 2033, growing at a CAGR of 13.1% during the forecast period 2025-2033. DNA sequencing refers to the process of determining the precise order of nucleotides within a DNA molecule and is a foundational technology in genomics, precision medicine, and life sciences research.

The market is experiencing strong growth driven by the rising adoption of next-generation sequencing (NGS) technologies, expanding applications in oncology, rare disease diagnostics, reproductive health, and infectious disease surveillance, and declining sequencing costs. Increased investments in genomics research, large-scale population genomics programs, and advancements in bioinformatics and data analytics are further accelerating adoption. Additionally, growing use of DNA sequencing in drug discovery, companion diagnostics, and personalized medicine continues to expand the market's clinical and commercial potential worldwide.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/dna-sequencing-market?sai-v

The DNA Sequencing Market is the sector that develops and supplies technologies, instruments, reagents, and services used to determine the precise order of nucleotides in DNA for research, diagnostics, and clinical applications.

Key Developments
✅ October 2025: Research laboratories and clinical centers in North America used next-generation sequencing (NGS) platforms for genomic research, clinical diagnostics, and precision medicine applications.

✅ September 2025: European healthcare institutions integrated DNA sequencing workflows with laboratory information management systems (LIMS) to support standardized genomic data processing.

✅ August 2025: Asia-Pacific genomics laboratories adopted high-throughput DNA sequencing technologies for population genomics, oncology research, and infectious disease studies.

✅ July 2025: Sequencing technology providers enhanced bioinformatics software compatibility with DNA sequencing instruments for data analysis and interpretation.

✅ May 2025: Pharmaceutical and biotechnology companies utilized DNA sequencing in drug discovery, biomarker identification, and target validation studies.

✅ March 2025: Academic research institutions conducted whole-genome, whole-exome, and targeted sequencing studies across human, plant, and microbial genomes.

Mergers & Acquisitions
✅ November 2025: A global life sciences company acquired a genomics technology firm to expand its DNA sequencing platforms and data analysis capabilities.

✅ August 2025: A European molecular diagnostics company partnered with a sequencing technology provider to integrate sequencing-based diagnostic workflows.

✅ June 2025: An Asia-Pacific biotechnology company acquired a genomics services provider to strengthen its DNA sequencing and sample analysis offerings.

Key Players
Veolia | Suez | Waste Management Inc. | FCC Environment CEE | Hitachi Zosen Corporation | Clean Harbors, Inc. | Covanta Holding Corporation | Biffa Group Limited | Daiseki Co., Ltd | Remondis SE & Co. KG

Key Highlights

Veolia - Holds a share of 18.6 percent: Leads the market with a broad portfolio in waste treatment, recycling, and environmental services, supported by strong global operations and advanced waste-to-resource technologies.

Suez - Holds a share of 15.9 percent: Maintains a strong position through integrated waste management solutions, circular economy initiatives, and long-term municipal and industrial contracts worldwide.

Waste Management Inc. - Holds a share of 14.8 percent: Dominates the North American market with extensive landfill, recycling, and hazardous waste infrastructure, backed by operational scale and stable service revenues.

FCC Environment CEE - Holds a share of 8.7 percent: Strengthens its presence through municipal solid waste management and recycling services across Central and Eastern Europe, supported by regional contracts.

Hitachi Zosen Corporation - Holds a share of 9.2 percent: Plays a key role through waste-to-energy plants, incineration systems, and advanced environmental engineering solutions.

Clean Harbors, Inc. - Holds a share of 7.9 percent: Specializes in hazardous waste management, industrial cleaning, and environmental services, serving energy, manufacturing, and chemical sectors.

Covanta Holding Corporation - Holds a share of 7.1 percent: Focuses on energy-from-waste facilities and sustainable disposal solutions, contributing significantly to waste-to-energy capacity.

Biffa Group Limited - Holds a share of 6.4 percent: A major regional player with strong capabilities in recycling, collection, and resource recovery, particularly in the United Kingdom.

Daiseki Co., Ltd - Holds a share of 5.8 percent: Supports market growth through industrial waste treatment, recycling, and environmental remediation services, mainly across Japan.

Remondis SE & Co. KG - Holds a share of 5.6 percent: Operates as a key European player offering comprehensive recycling, water, and waste management services with a strong logistics network.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=dna-sequencing-market?sai-v
(Purchase 2 or more Reports and get 50% Discount)

Market Drivers
- Increasing demand for genomic applications in clinical diagnostics, oncology, rare disease detection, and infectious disease surveillance.

- Growing adoption of next-generation sequencing (NGS) technologies offering higher throughput, lower cost, and faster results compared with traditional methods.

- Expanding use of DNA sequencing in precision medicine, pharmacogenomics, and personalized treatment strategies.

- Rising investments in large-scale genomic research projects and national genome initiatives.

- Advancements in sequencing platforms, bioinformatics tools, and sample preparation techniques.

- Increasing collaborations between academic research institutions, biotechnology companies, and healthcare providers.

- Supportive government funding and favorable regulatory frameworks for genomic research and diagnostics.

Industry Developments
- Launch of next-generation and third-generation sequencing platforms with improved accuracy, speed, and scalability.

- Expansion of sequencing services including whole-genome, whole-exome, and targeted sequencing.

- Integration of AI-driven and cloud-based bioinformatics tools for faster and more accurate genomic data analysis.

- Strategic partnerships between sequencing technology providers and clinical research organizations.

- Focus on reducing per-sample sequencing costs to increase clinical and consumer accessibility.

- Rising mergers, acquisitions, and investments in genomic technology and sequencing service companies.

- Growth in consumables, reagents, and service portfolios supporting diverse research and clinical applications.

Regional Insights
North America - 48% share: "Driven by strong genomic research infrastructure, high healthcare R&D spending, early adoption of advanced sequencing technologies, and large-scale multi-omics initiatives."

Europe - 29% share: "Supported by robust public research networks, precision medicine adoption, favorable regulations, and collaborative genomic programs across countries."

Asia Pacific - 20% share: "Fueled by rapid healthcare expansion, increasing government funding for genomics, national sequencing initiatives, and rising biotechnology investments."

Latin America - 2% share: "Boosted by growing awareness of genetic testing, expanding sequencing services, and improving biotechnology infrastructure."

Middle East & Africa - 1% share: "Driven by increasing healthcare investments, emerging genomics programs, and gradual adoption of sequencing technologies in research and diagnostics."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/dna-sequencing-market?sai-v

Key Segments
By Product Type
Instruments dominate the market due to continuous advancements in sequencing platforms, automation, and high-throughput capabilities that support large-scale genomic analysis. Consumables represent a significant and recurring revenue segment, driven by frequent use of reagents, kits, flow cells, and sample preparation materials in routine sequencing workflows. Other product types contribute steadily, including software and ancillary accessories that support data analysis, storage, and system optimization.

By Sequencing Type
Next-generation sequencing (NGS) holds the largest market share owing to its high speed, scalability, and cost-effectiveness for large-volume sequencing applications. Its widespread adoption across research, clinical diagnostics, and population genomics continues to drive growth. Sanger sequencing maintains steady demand as a gold-standard technique for validation, small-scale sequencing, and targeted analysis. Other sequencing technologies, including emerging and hybrid approaches, continue to support niche and specialized applications.

By Application
Diagnostics represent the leading application segment, driven by increasing use of sequencing technologies for disease detection, oncology testing, and genetic disorder screening. Personalized medicine is witnessing rapid growth as genomic insights enable targeted therapies, precision treatment planning, and improved patient outcomes. Other applications, including research and drug discovery, contribute consistently to overall market expansion.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.